within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A03A_DrugsForFunctionalGastrointestinalDisorders.A03AB17_TiemoniumIodide;
model TiemoniumIodide 
   extends Pharmacolibrary.Drugs.ATC.A.A03AB17;

  annotation(Documentation(
    info ="<html><body><p>Tiemonium iodide is a synthetic anticholinergic and spasmolytic agent that is used to relieve gastrointestinal and urinary tract smooth muscle spasms. It reduces contractions of smooth muscle and is sometimes used in the symptomatic treatment of gastrointestinal disorders such as dyspepsia, irritable bowel syndrome, or in renal or biliary colic. The drug is not approved in the US or Western Europe but is used in some Asian and African countries.</p><h4>Pharmacokinetics</h4><p>No pharmacokinetic parameters or compartmental models for tiemonium iodide have been identified in published literature as of 2024. Estimates provided here are based on general pharmacokinetic properties of similar anticholinergic spasmolytics.</p><h4>References</h4><ol><li><p>Scoular, IT, et al., &amp; Turner, P (1976). Human studies on the bioavailability of a quaternary ammonium compounds, tiemonium iodide and tiemonium methosulphate. <i>Current medical research and opinion</i> 4(10) 732â€“738. DOI:<a href=&quot;https://doi.org/10.1185/03007997609112009&quot;>10.1185/03007997609112009</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/1052164/&quot;>https://pubmed.ncbi.nlm.nih.gov/1052164</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end TiemoniumIodide;
